Business · 07/10/2022Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for Human Drug Compounding Under Federal Law
Summary
The Food and Drug Administration (FDA) has submitted a request to the Office of Management and Budget (OMB) for review and clearance of a proposed collection of information related to human drug compounding under the Federal Food, Drug, and Cosmetic Act, specifically sections 503A and 503B.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →